Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la base de données des Annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
IbafloxacinPDL I DEC / 13
Ibandronic acid and its saltsF1 I SEP / 06
Ibogaine or its salts or derivatives or analoguesPDL I MAY / 17
Ibrutinib or its saltsPDL I DEC / 14
Ibuprofen or its saltsPDL

except when sold in an oral dosage form that provides 400 mg or less per dosage unit or in a modified-release oral dosage form that provides 600 mg or less per dosage unit

I AUG / 16
Ibuprofen or its salts. when sold in an immediate release dosage form containing 400 mg or less per oral dosage unit (in package sizes exceeding 18,000 mg) III FEB / 12
Ibuprofen or its salts..

when sold in a modified-release oral dosage form that provides 600 mg or less per dosage unit

III AUG / 16
Ibuprofen or its salts... when sold in an immediate release dosage form containing 400 mg or less per oral dosage unit (in package sizes of up to 18,000 mg) U FEB / 12
Ibutilide and its salts and derivativesF1 I DEC / 02
Icatibant or its saltsPDL

including but not limited to Icatibant acetate

I AUG / 14
Idarubicin and its saltsF1 I SEP / 98
IdarucizumabPDL I AUG / 16
IdebenonePDL I DEC / 13
IdelalisibPDL I MAY / 15
IdoxuridineF1 I SEP / 98
IdursulfaseFR I FEB / 09
IfosfamideF1 I SEP / 98
Imatinib and its saltsF1 I OCT / 03
ImigluceraseF1 I SEP / 98
Imipenem and its salts and derivativesF1 I SEP / 98
Imipramine and its saltsF1 I SEP / 98
Imiquimod and its saltsF1 I MAY / 00
Immune globulin products I FEB / 02
Indacaterol or its salts or derivativesPDL I DEC / 13
Indapamide and its saltsF1 I SEP / 98
Indinavir and its saltsF1 I SEP / 98
IndomethacinF1 I SEP / 98
InfliximabF1 I JUL / 03
Influenza vaccine II DEC / 98
Inhaled human insulinF1 I JUN / 08
Inhaled human insulin.F1 I DEC / 08
InosiplexF1 I SEP / 98
Inositol niacinate U DEC / 98
Inotuzumab ozogamicinPDL I MAY / 18
InsulinD II SEP / 98
InterferonF1 I SEP / 98
Invermectin and its derivatives, for human use or for veterinary useF1 when sold for intramuscular injection into horses or for administration to dogs and cats I MAY / 04
Iodinated glycerol II SEP / 98
Iodine and its salts and derivatives except topical preparations or in oral doses of 1 mg or less per day II DEC / 98
Iodine and its salts and derivatives for topical use III SEP / 98
Iodochlorhydroxyquin for topical use II SEP / 98
IodochlorohydroxyquinF1 except in preparations for topical use on the skin I SEP / 98
Ipecac and its extracts and derivatives when used as an emetic II OCT / 98
Ipecac and its extracts and derivatives. for use other than as an emetic U OCT / 98
IpilimumabPDL I DEC / 13
Ipratropium and its saltsF1 I SEP / 98
Iproniazid and its saltsF1 I SEP / 98
Irbesartan and its saltsF1 I SEP / 99
Irinotecan and its saltsF1 I SEP / 98
Iron and its salts and derivatives in preparations with more than 30 mg elemental iron per solid dosage unit or 5 mL oral liquid II SEP / 98
Iron and its salts and derivatives. in preparations containing 30 mg or less elemental iron per solid dosage unit or 5 ml oral liquid U
Iron derivativesPDL

for human use, including but not limited to ferumoxytol for parenteral use only

I DEC / 13
Iron derivativesPDL

for veterinary use, including but not limited to ferumoxytol for all routes of administration but parenteral

I DEC / 13
Isocarboxazid and its saltsF1 I SEP / 98
IsofluraneF1 I SEP / 98
IsomethadoneN I JUN / 02
IsoniazidF1 I SEP / 98
Isopropamide and its salts I SEP / 98
Isopropyl myristate in concentration of 50%

for use in the treatment of head lice

III JUL / 07
IsoproterenolF1 Isoprenaline and its salts I SEP / 98
Isosorbide and its salts I SEP / 98
Isotretinoin and its saltsF1 I SEP / 98
Isoxsuprine and its saltsF1 I SEP / 98
Isradipine and its saltsF1 I SEP / 98
Itraconazole and its saltsF1 I SEP / 98
Ivabradine or its salts or derivativesPDL I FEB / 17
Ivermectin and its derivativesF1 for human use or for veterinary use when sold for intramuscular injection into horses or for administration to dogs and cats I MAY / 04
Ixazomib or its derivativesPDL I NOV / 16
IxekizumabPDL I AUG / 16

69 résultats


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations}
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drus Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled